|
OMA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.622500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.379700E-03 |
| Normal-vs-Stage2 |
1.742610E-01 |
| Normal-vs-Stage3 |
1.014750E-04 |
| Normal-vs-Stage4 |
6.678000E-01 |
| Stage1-vs-Stage2 |
7.171600E-01 |
| Stage1-vs-Stage3 |
3.416300E-02 |
| Stage1-vs-Stage4 |
8.292400E-01 |
| Stage2-vs-Stage3 |
7.576500E-02 |
| Stage2-vs-Stage4 |
9.280200E-01 |
| Stage3-vs-Stage4 |
4.260200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.881900E-02 |
| Normal-vs-AfricanAmerican |
4.405100E-04 |
| Normal-vs-Asian |
3.725600E-02 |
| Caucasian-vs-AfricanAmerican |
2.320400E-02 |
| Caucasian-vs-Asian |
4.295000E-01 |
| AfricanAmerican-vs-Asian |
9.895800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.071710E-02 |
| Normal-vs-Female |
8.620600E-03 |
| Male-vs-Female |
3.951200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.455700E-02 |
| Normal-vs-Extreme_Weight |
1.347530E-02 |
| Normal-vs-Obese |
2.961900E-03 |
| Normal-vs-Extreme_Obese |
3.731600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.192800E-01 |
| Normal_Weight-vs-Obese |
5.848600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.338600E-01 |
| Extreme_Weight-vs-Obese |
4.004600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.814000E-01 |
| Obese-vs-Extreme_Obese |
3.595600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.547900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.651600E-02 |
| Normal-vs-Age(61-80Yrs) |
4.504900E-03 |
| Normal-vs-Age(81-100Yrs) |
7.623300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.849000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.752200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.548000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.369800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.289000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.305200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.466800E-01 |
| Normal-VS-Type2 PRCC |
2.597800E-04 |
| Normal-VS-KIRP CIMP |
5.85490000000188E-05 |
| Normal-VS-Unclassified PRCC |
2.953900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.164800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.916110E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.199900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.519190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.675600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.201700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.981470E-03 |
| Normal-vs-N1 |
1.602230E-01 |
| Normal-vs-N2 |
7.486000E-02 |
| N0-vs-N1 |
8.215600E-01 |
| N0-vs-N2 |
7.029000E-01 |
| N1-vs-N2 |
7.664000E-01 |
|
|
